Kathleen Sereda Glaub
CIK 1619612 · last filed 2025-06-06
Kathleen Sereda Glaub is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for IOBT, was dated Jun 6, 2025. Across all open-market trades the lifetime net is −$786.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $164.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$164.4K
2
14
-$786.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IO Biotech, Inc. (IOBT) Delisted | Director | — | $0.05 | — | $0 | 5 | 2025-06-06 |
| CDXS | Director | 68,481 | $2.40 | $164.4K | -$786.6K | 9 | 2019-06-13 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-06 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-08 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-13 | CDXS | Grant (A) | +4,947 | $0 | EDGAR |
| 2018-09-27 | CDXS | Sell (S) | −14,492 | -$272.8K | EDGAR |
| 2018-09-20 | CDXS | Sell (S) | −20,094 | -$360.4K | EDGAR |
| 2018-07-20 | CDXS | Sell (S) | −10,000 | -$153.4K | EDGAR |
| 2018-06-12 | CDXS | Grant (A) | +5,923 | $0 | EDGAR |